Home | Contact us | Site map | Careers | Q&A | Advantages of Québec |
  SGF Profile  
  Investment Groups  
  Our Investments  
  Documentation Center  
By investment groups
By companies
By regions of Québec

By companies



CryoCath Technologies 

CryoCath is a medical technology company that leads the world in creating catheter and probe-based CryoTherapy products to treat cardiovascular disease. Traditionnaly, the use of freezing temperatures to treat diseased tissue has been limited by the inability to deliver the treatment in a minimally invasive manner. Cryocath has successfully overcome this obstacle by developing flexible, steerable, minimally invasive catheters to deliver cold therapy safely and effectively.

CryoCath is a public company based in Montréal and is listed on the Toronto Stock Exchange (TSX CYT)


SGF participation: 8% 


Home  |  Legal Notice  |  Corporate Policies  | 

 Copyright © SGF 2007